204 related articles for article (PubMed ID: 28073228)
1. [Statin intolerance].
Tonstad S
Tidsskr Nor Laegeforen; 2017 Jan; 137(1):36-38. PubMed ID: 28073228
[TBL] [Abstract][Full Text] [Related]
2. [Statin intolerance].
Graversen CB; Larsen ML; Schmidt EB
Ugeskr Laeger; 2015 Aug; 177(36):. PubMed ID: 26324293
[TBL] [Abstract][Full Text] [Related]
3. Clinical Profile of Statin Intolerance in the Phase 3 GAUSS-2 Study.
Cho L; Rocco M; Colquhoun D; Sullivan D; Rosenson RS; Dent R; Xue A; Scott R; Wasserman SM; Stroes E
Cardiovasc Drugs Ther; 2016 Jun; 30(3):297-304. PubMed ID: 26936841
[TBL] [Abstract][Full Text] [Related]
4. Effect of a monoclonal antibody to PCSK9 on low-density lipoprotein cholesterol levels in statin-intolerant patients: the GAUSS randomized trial.
Sullivan D; Olsson AG; Scott R; Kim JB; Xue A; Gebski V; Wasserman SM; Stein EA
JAMA; 2012 Dec; 308(23):2497-506. PubMed ID: 23128163
[TBL] [Abstract][Full Text] [Related]
5. Usefulness of compounds with monacolin K in a case of statins intolerance.
Parra-Virto A; Torres do Rego A; Demelo-Rodríguez P; Millán Núñez-Cortés J; Álvarez-Sala LA
Clin Investig Arterioscler; 2018; 30(6):268-270. PubMed ID: 30309697
[TBL] [Abstract][Full Text] [Related]
6. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management.
Stroes ES; Thompson PD; Corsini A; Vladutiu GD; Raal FJ; Ray KK; Roden M; Stein E; Tokgözoğlu L; Nordestgaard BG; Bruckert E; De Backer G; Krauss RM; Laufs U; Santos RD; Hegele RA; Hovingh GK; Leiter LA; Mach F; März W; Newman CB; Wiklund O; Jacobson TA; Catapano AL; Chapman MJ; Ginsberg HN;
Eur Heart J; 2015 May; 36(17):1012-22. PubMed ID: 25694464
[TBL] [Abstract][Full Text] [Related]
7. Overcoming toxicity and side-effects of lipid-lowering therapies.
Wilkinson MJ; Laffin LJ; Davidson MH
Best Pract Res Clin Endocrinol Metab; 2014 Jun; 28(3):439-52. PubMed ID: 24840269
[TBL] [Abstract][Full Text] [Related]
8. Needed: pragmatic clinical trials for statin-intolerant patients.
Maningat P; Breslow JL
N Engl J Med; 2011 Dec; 365(24):2250-1. PubMed ID: 22085320
[No Abstract] [Full Text] [Related]
9. Statin myopathy: a review of recent progress.
Mammen AL; Amato AA
Curr Opin Rheumatol; 2010 Nov; 22(6):644-50. PubMed ID: 20827205
[TBL] [Abstract][Full Text] [Related]
10. Strategies to overcome statin intolerance.
Agouridis AP; Nair DR; Mikhailidis DP
Expert Opin Drug Metab Toxicol; 2015 Jun; 11(6):851-5. PubMed ID: 25786568
[TBL] [Abstract][Full Text] [Related]
11. Statin safety: an overview and assessment of the data--2005.
Bays H
Am J Cardiol; 2006 Apr; 97(8A):6C-26C. PubMed ID: 16581330
[TBL] [Abstract][Full Text] [Related]
12. Risk of Neuropsychiatric Adverse Effects of Lipid-Lowering Drugs: A Mendelian Randomization Study.
Alghamdi J; Matou-Nasri S; Alghamdi F; Alghamdi S; Alfadhel M; Padmanabhan S
Int J Neuropsychopharmacol; 2018 Dec; 21(12):1067-1075. PubMed ID: 29986042
[TBL] [Abstract][Full Text] [Related]
13. Treatment Options for Statin-Associated Muscle Symptoms.
Laufs U; Scharnagl H; Halle M; Windler E; Endres M; März W
Dtsch Arztebl Int; 2015 Oct; 112(44):748-55. PubMed ID: 26575138
[TBL] [Abstract][Full Text] [Related]
14. Proprotein Convertase Subtilisin/Kexin Type 9 Antibody and Statin-Associated Autoimmune Myopathy.
de Dios García-Díaz J; Corral-Bueno IM; Mesa-Latorre JM; Lozano-Durán C; Hernández-Ahijado C
Ann Intern Med; 2019 Jul; 171(1):68-69. PubMed ID: 30776798
[No Abstract] [Full Text] [Related]
15. An overview of statin-induced myopathy and perspectives for the future.
Nikolic D; Banach M; Chianetta R; Luzzu LM; Pantea Stoian A; Diaconu CC; Citarrella R; Montalto G; Rizzo M
Expert Opin Drug Saf; 2020 May; 19(5):601-615. PubMed ID: 32233708
[No Abstract] [Full Text] [Related]
16. Lipid-lowering drug prescriptions in a group of Colombian patients.
Gaviria-Mendoza A; Machado-Duque ME; Machado-Alba JE
Biomedica; 2019 Dec; 39(4):759-768. PubMed ID: 31860186
[TBL] [Abstract][Full Text] [Related]
17. [Approach to Patients with Statin Intolerance: Evidence-Based Review].
Almeida JT; Esteves AL; Martins F; Palma I
Acta Med Port; 2020 Jan; 33(1):49-57. PubMed ID: 31928603
[TBL] [Abstract][Full Text] [Related]
18. Statin-induced myopathy: a review and update.
Abd TT; Jacobson TA
Expert Opin Drug Saf; 2011 May; 10(3):373-87. PubMed ID: 21342078
[TBL] [Abstract][Full Text] [Related]
19. Precision Medicine and Personalized Management of Lipoprotein and Lipid Disorders in Chronic and End-Stage Kidney Disease.
Streja E; Streja DA; Soohoo M; Kleine CE; Hsiung JT; Park C; Moradi H
Semin Nephrol; 2018 Jul; 38(4):369-382. PubMed ID: 30082057
[TBL] [Abstract][Full Text] [Related]
20. [In process].
Reisdorf S
Med Monatsschr Pharm; 2017 Jun; 40(6):271-3. PubMed ID: 29979855
[No Abstract] [Full Text] [Related]
[Next] [New Search]